Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (0.05%), Hang Seng Futures +0.83%, ASX SPI 200 (0.33%), S&P Futures (0.04%)

Aug 28 ,2025

  • Synopsis:

    • Asian markets set for mixed start to Friday trade. Futures signaling opening declines in Japan and Australia, and positive start in Hong Kong. S&P 500 futures flat after US indexes logged mild gains on Thursday. Australian bonds firming, tracking earlier Treasury curve bull flattening. FX markets steady after dollar index eased slightly. Crude pulling back from earlier highs while gold flat. Bitcoin continues to fluctuate.

    • Alibaba (~9988.HK~) reports quarterly earnings later Friday. Shares sold off Thursday alongside food delivery peers in wake of Meituan's (~3690.HK~) warning of sizable losses due to effects of intense price competition. Alibaba's results expected to show similar trends to Meituan and JD.com (~9618.HK~) while market will be eyeing company's investment strategy as an indicator of future competition intensity. Another focus will be on extent of AI monetization though forecasts are for tepid AI-driven revenue growth.

    • In other corporate developments, Nvidia (~NVDA~) CEO Jensen Huang confirmed talks with White House about selling Blackwell chips to China but that process will take time. Cambricon Technologies (~688256.CH~) issued letter to shareholders Thursday warning of significant trading risk with stock rally deviating from fundamentals. Asia earnings continue to roll through with China's major banks reporting.

    • Tokyo core inflation eased in-line with forecasts to lowest since March while Japan unemployment rate unexpected fell to since Dec-2019. Data comes amid BOJ rate hike speculation with market-implied odds of a 25 bp increase in October hitting ~60%. In speech Thursday, board member Nakagawa reaffirmed that policy adjustments will continue if economic outlook is realized. US core PCE the other main data point on Friday, forecast to show fourth-straight monthly increase to highest since February.

  • Pre-open Company News:

    • 002294.CH -- NMPA accepts submission of Salubris Pharmaceuticals's application for trial of SAL0140 for chronic kidney disease

    • PBH.AU -- MIXI reiterates it will not accept betr's offer for its PointsBet shares

    • 6957.JP -- MinebeaMitsumi extends tender offer for Shibaura Electronics to 11-Sep

    • 688520.CH -- Sinocelltech Group reports H1 net income attributable (CNY33.8M) vs year-ago CNY125.7M

    • 601568.CH -- Shaanxi Beiyuan Chemical Industry Group reports H1 net income attributable CNY138.3M, +2% vs year-ago CNY135.7M

    • 2607.HK -- Shanghai Pharmaceuticals Holding reports H1 net income attributable CNY4.46B vs guidance CNY4.45B and year-ago CNY2.94B

    • 601568.CH -- Shaanxi Beiyuan Chemical Industry Group reports H1 operational data

    • 601108.CH -- Caitong Securities reports H1 net income attributable CNY1.08B, +17% vs year-ago CNY927.1M

    • GOOS.CN -- ANTA Sports Products says it is not a party to potential acquisition of Canada Goose in response to news reports

    • 600887.CH -- Inner Mongolia Yili Industrial Group reports H1 net income attributable CNY7.20B, (4%) vs year-ago CNY7.53B

    • 600887.CH -- Inner Mongolia Yili Industrial Group reports H1 operating data

    • 9699.HK -- Hangzhou SF Intra-city Industrial reports H1 net income attributable CNY137.0M, +120% vs year-ago CNY62.2M

    • 603707.CH -- Nanjing King-friend Biochemical Pharmaceutical Co. reports H1 net income attributable CNY286.3M, (29%) vs year-ago CNY405.0M

    • 2015.HK -- Li Auto reports Q2 non-GAAP EPADS CNY1.37 vs FactSet CNY1.66 [9 est, CNY1.10-2.45]

  • On Deck:

    • China:

      • Earnings:

        • Zhejiang Supor (002032.CH), Shenwan Hongyuan Group (000166.CH), Hubei Biocause Pharmaceutical (000627.CH), Shenzhen Gas (601139.CH), Qilu Bank (601665.CH), Huatai Securities (601688.CH)

    • Hong Kong:

      • Earnings:

        • FWD Group Holdings (1828.HK), Everest Medicines (1952.HK), Agricultural Bank of China (1288.HK), Industrial & Commercial Bank of China (1398.HK), JS Global Lifestyle (1691.HK), Mobvista (1860.HK), BOC Hong Kong (Holdings) (2388.HK), Autostreets Development (2443.HK), Shanghai Electric Group (2727.HK), China Railway Group (390.HK), China International Capital (3908.HK), Bank of China (3988.HK), Ganglong China Property Group (6968.HK), Dalipal Holdings (1921.HK), Haichang Ocean Park Holdings (2255.HK), HealthyWay, Inc. (2587.HK), LVGEM (China) Real Estate Investment (95.HK), Seazen Group (1030.HK), Zoomlion Heavy Industry Science & Technology (1157.HK), Jacobio Pharmaceuticals Group (1167.HK), Yankuang Energy Group (1171.HK), Zhuguang Holdings Group (1176.HK), Powerlong Real Estate Holdings (1238.HK), 3D Medicines (1244.HK), LifeTech Scientific (1302.HK), Central China Securities (1375.HK), China Merchants Port Holdings (144.HK), China Reinsurance (Group) (1508.HK), 3SBio Inc (1530.HK), Metallurgical Corp. of China (1618.HK), Postal Savings Bank of China (1658.HK), Central New Energy Holding Group (1735.HK), Fantasia Holdings Group (1777.HK), Colour Life Services Group (1778.HK), Xinte Energy (1799.HK), Zensun Enterprises (185.HK), China Risun Group (1907.HK), MOG Digitech Holdings (1942.HK), Cathay Group Holdings (1981.HK), China Minsheng Banking (1988.HK), Melco International Development (200.HK), China Lesso Group Holdings (2128.HK), Guangzhou Automobile Group (2238.HK), Gushengtang Holdings (2273.HK), Glory Health Industry (2329.HK), XD Inc (2400.HK), MedSci Healthcare Holdings (2415.HK), Shun Tak Holdings (242.HK), Sanergy Group (2459.HK), China Resources Beverage (Holdings) (2460.HK), Black Sesame International Holding (2533.HK), Easou Technology Holdings (2550.HK), Sichuan Baicha Baidao (2555.HK), Geekplus Technology (2590.HK), Cloudbreak Pharma (2592.HK), CITIC Ltd (267.HK), China CITIC Financial Asset Management Co. (2799.HK), BYD Electronic (International) (285.HK), COSCO SHIPPING Development (2866.HK), Ronshine China Holdings (3301.HK), Bank of Communications (3328.HK), Greenland Hong Kong Holdings (337.HK), Agile Group Holdings (3383.HK), Legend Holdings (3396.HK), GCL Technology Holdings (3800.HK), China Harmony Auto Holding (3836.HK), Medtide (3880.HK), China Merchants Bank (3968.HK), Shandong Hi-Speed Holdings Group (412.HK), Sihuan Pharmaceutical Holdings Group (460.HK), United Energy Group (467.HK), GOME Retail Holdings (493.HK), China Traditional Chinese Medicine Holdings (570.HK), Tongdao Liepin Group (6100.HK), China High Speed Transmission Equipment Group (658.HK), Flowing Cloud Technology (6610.HK), Evergrande Property Services Group (6666.HK), Star Plus Legend Holdings (6683.HK), China Eastern Airlines (670.HK), China Everbright Bank (6818.HK), Yangtze Optical Fibre & Cable Joint Stock (6869.HK), Shuangdeng Group (6960.HK), Central China Real Estate (832.HK), MicroPort Scientific (853.HK), China Construction Bank (939.HK), Longfor Group Holdings (960.HK), Linmon Media (9857.HK), Helens International Holdings (9869.HK), UBTECH Robotics (9880.HK), Nanjing Leads Biolabs (9887.HK), Deep Source Holdings (990.HK), Huijing Holdings (9968.HK)

    • Japan:

      • Economic:

        • 08:50 JST: Industrial Production SA M/M (Preliminary); consensus (1.2%)

        • 08:50 JST: Retail Sales NSA Y/Y (Preliminary); consensus +1.9%

        • 14:00 JST: Housing Starts NSA Y/Y; consensus (9.5%)

      • Earnings:

        • Tri Chemical Laboratories (4369.JP)

    • Australia:

      • Economic:

        • 11:30 AEST: Private Sector Credit M/M; consensus +0.6%

      • Earnings:

        • Immutep (IMM.AU), Jupiter Mines (JMS.AU), PointsBet Holdings (PBH.AU), 3P Learning (3PL.AU), Alpha HPA (A4N.AU), Boss Energy (BOE.AU), Enero Group (EGG.AU), Frontier Digital Ventures (FDV.AU), Harvey Norman Holdings (HVN.AU), Immuron (IMC.AU), Mayne Pharma Group (MYX.AU), Star Entertainment Group (SGR.AU), Structural Monitoring Systems (SMN.AU), Waypoint REIT (WPR.AU)

    • India:

      • Economic:

        • 05:30 IST: GDP NSA Y/Y; consensus +6.6%

  • Market Data:

    • Gold (Dec 25): +$0.90 or +0.03% to $3475.20

    • WTI Crude (Oct 25): ($0.41) or (0.63%) to $64.19

    • $-¥: (0.50) or (0.34%) to 146.9060

    • $-KRW: (8.89) or (0.64%) to 1384.4100

    • A$-$: +0.00 or +0.40% to 0.6530

    • $-INR: (0.07) or (0.08%) to 87.5914

    • $-CNY: (0.02) or (0.34%) to 7.1297

  • If you would like to receive the Asian Market Preview daily, please search for Asia Pre-Market Updates in Alert Manager.

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE